Oct. 17 at 12:52 PM
$EW gearing up for Q3 earnings — can it keep beating estimates? 📈
With a Zacks Rank #3 and +0.47% Earnings ESP, the setup looks promising. TAVR segment expected to shine with strong performance in the U.S. and Europe, while TMTT gains global traction with PASCAL.
Full earnings preview here 👉 https://www.zacks.com/stock/news/2770899/robust-tavr-growth-to-drive-edwards-lifesciences-q3-earnings?cid=sm-stocktwits-2-2770899-body-16536&ADID=SYND_STOCKTWITS_TWEET_2_2770899_BODY_16536